New research led by King's College London suggests that a simple test already used in clinics could provide valuable additional insights into how the body's immune system responds to cancer, without ...
Knocking on molecular alterations in advanced gastric cancer (AGC). A phase II study of the c-Met inhibitor tivantinib (tiv) in combination with FOLFOX for the treatment of patients (pts) with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results